Evidence map›Paper›PMID 32626534›Full record

ArticleJournal of Cancer2020

Identification of the Mutational Landscape of Gynecological Malignancies.

Suresh Chava, Romi Gupta

Abstract read
In one paragraph

Article in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. International journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Molecular Landscape of Vulvar Squamous Cell Carcinoma.International journal of molecular sciences · 2021
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Suresh ChavaDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Romi GuptaDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.

Funding

A NOVEL DRUGGABLE GENETIC VULNERABILITY PATHWAY IN MELANOMAR01CA200919 · NCI · YALE UNIVERSITY · PI WAJAPEYEE, NARENDRA · 2016 to 2020
$1.8M
Nucleoporin NUP205-driven Novel Pathway in Melanoma Tumor Growth and MetastasisR01CA196566 · NCI · YALE UNIVERSITY · PI WAJAPEYEE, NARENDRA · 2016 to 2020
$1.8M
A DRUGGABLE CHROMATIN MODIFIER PATHWAY IN HCCR21CA229927 · NCI · YALE UNIVERSITY · PI GUPTA, ROMI, WAJAPEYEE, NARENDRA · 2018 to 2019
$399k
PERSONALIZED THERAPY FOR p16-DEFICIENT MELANOMAR03CA221926 · NCI · YALE UNIVERSITY · PI GUPTA, ROMI · 2018 to 2019
$158k
A NOVEL EPIGENETIC IMMUNOTHERAPY FOR OVARIAN CANCER TREATMENTR03CA230815 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUPTA, ROMI · 2019 to 2020
$149k
NCI NIH HHS R01 CA196566NCI NIH HHS R01 CA200919NCI NIH HHS R03 CA221926NCI NIH HHS R03 CA230815NCI NIH HHS R21 CA229927
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkergynecological malignanciesOncomineTCGAtherapeutic

Identifiers

PMID32626534
PMCPMC7330690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.